Caro JJ - Search Results

1

A discrete-event simulation of smoking-cessation strategies based on varenicline pivotal trial data.

Xenakis JG, Kinter ET, Ishak KJ, Ward AJ, Marton JP, Willke RJ, Davies S, Caro JJ. Xenakis JG, et al. Among authors: caro jj. Pharmacoeconomics. 2011 Jun;29(6):497-510. doi: 10.2165/11589230-000000000-00000. Pharmacoeconomics. 2011. PMID: 21452908

2

Economic analysis of initial HIV treatment. Efavirenz- versus indinavir-containing triple therapy.

Caro JJ, O'Brien JA, Migliaccio-Walle K, Raggio G. Caro JJ, et al. Pharmacoeconomics. 2001 Jan;19(1):95-104. doi: 10.2165/00019053-200119010-00007. Pharmacoeconomics. 2001. PMID: 11252549

3

Healing and relapse rates in gastroesophageal reflux disease treated with the newer proton-pump inhibitors lansoprazole, rabeprazole, and pantoprazole compared with omeprazole, ranitidine, and placebo: evidence from randomized clinical trials.

Caro JJ, Salas M, Ward A. Caro JJ, et al. Clin Ther. 2001 Jul;23(7):998-1017. doi: 10.1016/s0149-2918(01)80087-4. Clin Ther. 2001. PMID: 11519776

4

Assessment of health economics in Alzheimer's disease (AHEAD): galantamine treatment in Canada.

Getsios D, Caro JJ, Caro G, Ishak K; AHEAD Study Group. Getsios D, et al. Among authors: caro jj, caro g. Neurology. 2001 Sep 25;57(6):972-8. doi: 10.1212/wnl.57.6.972. Neurology. 2001. PMID: 11571319

5

Lifetime costs of complications resulting from type 2 diabetes in the U.S.

Caro JJ, Ward AJ, O'Brien JA. Caro JJ, et al. Diabetes Care. 2002 Mar;25(3):476-81. doi: 10.2337/diacare.25.3.476. Diabetes Care. 2002. PMID: 11874933

6

Cost effectiveness of tinzaparin sodium versus unfractionated heparin in the treatment of proximal deep vein thrombosis.

Caro JJ, Getsios D, Caro I, O'Brien JA. Caro JJ, et al. Among authors: caro i. Pharmacoeconomics. 2002;20(9):593-602. doi: 10.2165/00019053-200220090-00003. Pharmacoeconomics. 2002. PMID: 12141887

7

Assessment of Health Economics in Alzheimer's Disease (AHEAD): treatment with galantamine in Sweden.

Garfield FB, Getsios D, Caro JJ, Wimo A, Winblad B. Garfield FB, et al. Among authors: caro jj. Pharmacoeconomics. 2002;20(9):629-37. doi: 10.2165/00019053-200220090-00006. Pharmacoeconomics. 2002. PMID: 12141890

8

Economic analysis of galantamine, a cholinesterase inhibitor, in the treatment of patients with mild to moderate Alzheimer's disease in the Netherlands.

Caro JJ, Salas M, Ward A, Getsios D, Mehnert A; AHEAD Study Group. Assessment of Health Economics in Alzheimer's Disease. Caro JJ, et al. Dement Geriatr Cogn Disord. 2002;14(2):84-9. doi: 10.1159/000064929. Dement Geriatr Cogn Disord. 2002. PMID: 12145455

9

Describing cognitive decline of patients at the mild or moderate stages of Alzheimer's disease using the Standardized MMSE.

Ward A, Caro JJ, Kelley H, Eggleston A, Molloy W. Ward A, et al. Among authors: caro jj. Int Psychogeriatr. 2002 Sep;14(3):249-58. doi: 10.1017/s1041610202008451. Int Psychogeriatr. 2002. PMID: 12475086

10

Economic evaluation of galantamine in the treatment of mild to moderate Alzheimer's disease in the United States.

Migliaccio-Walle K, Getsios D, Caro JJ, Ishak KJ, O'Brien JA, Papadopoulos G; AHEAD Study Group. Migliaccio-Walle K, et al. Among authors: caro jj. Clin Ther. 2003 Jun;25(6):1806-25. doi: 10.1016/s0149-2918(03)80171-6. Clin Ther. 2003. PMID: 12860500 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

200 results

Search Page

Filters